97 related articles for article (PubMed ID: 8095467)
1. Interactions between U-50,488H and sigma receptor antagonists: EEG, EEG power spectral and behavioral correlates.
Young GA; Hudson GM; Stamidis H; Steinfels GF
Eur J Pharmacol; 1993 Feb; 231(3):473-6. PubMed ID: 8095467
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of naloxone-sensitive and naloxone-insensitive effects of U-50,488H.
Young GA
Pharmacol Biochem Behav; 1989 May; 33(1):215-7. PubMed ID: 2780779
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil.
Contreras PC; Ragan DM; Bremer ME; Lanthorn TH; Gray NM; Iyengar S; Jacobson AE; Rice KC; de Costa BR
Brain Res; 1991 Apr; 546(1):79-82. PubMed ID: 1649669
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
Veeranna ; Reddy PL; Bhargava HN
Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939
[TBL] [Abstract][Full Text] [Related]
6. Effects of kappa, sigma, and phencyclidine receptors agonists in rat tail arteries of spontaneously hypertensive rats.
Gao J; Bao WL; Sun FY; Zhang AZ
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):111-4. PubMed ID: 8010101
[TBL] [Abstract][Full Text] [Related]
7. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
[TBL] [Abstract][Full Text] [Related]
8. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
Ukai M; Kameyama T
Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Bhargava HN; Thorat SN
Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
[TBL] [Abstract][Full Text] [Related]
10. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
Leyton M; Stewart J
Brain Res; 1992 Oct; 594(1):56-74. PubMed ID: 1334765
[TBL] [Abstract][Full Text] [Related]
11. The interaction between kappa-opioid agonist, U-50, 488H, and kainic acid: behavioral and histological assessments.
Lason W; Simpson JN; McGinty JF
Brain Res; 1989 Mar; 482(2):333-9. PubMed ID: 2539886
[TBL] [Abstract][Full Text] [Related]
12. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia.
Richter A; Löscher W
Eur J Pharmacol; 1993 May; 236(2):289-94. PubMed ID: 8391460
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
16. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
17. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
19. Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors.
Langlois A; Diop L; Friese N; Pascaud X; Junien JL; Dahl SG; Rivière PJ
Eur J Pharmacol; 1997 Apr; 324(2-3):211-7. PubMed ID: 9145774
[TBL] [Abstract][Full Text] [Related]
20. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
Bhargava HN; Ramarao P; Gulati A
Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
